Breadcrumb
NIH Guide: Weekly Index for October 7, 2022
Weekly NIH Funding Opportunities and Notices
October 7, 2022
Policy Notices
-
Notice to Extend PA-20-028, Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18)
(NOT-HS-22-024)Agency for Healthcare Research and Quality
-
Reminder: NIH Natural Disaster Policy Hurricanes Fiona and Ian
(NOT-OD-22-221)National Institutes of Health
General Notices
-
Notice of Information for RFA-CA-22-045, NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
(NOT-CA-23-002)National Cancer Institute
-
Notice of Informational Webinar for PAR-22-180 "Maximizing Investigators' Research Award (MIRA)"
(NOT-GM-23-003)National Institute of General Medical Sciences
-
Notice of Training and REDCap Demonstration for the Implementation of NICHD's CDE Recommendations for COVID-19 Research in Pediatric, Pregnant, and Lactating Populations Published Through the NIEHS Disaster Research Response (DR2) Portal
(NOT-HD-22-047)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Data Sharing Policy for the National Institute of Mental Health
(NOT-MH-23-100)National Institute of Mental Health
-
Notice Announcing the Expectations for the Collection of Common Data Elements for HIV-Funded Research at the National Institute of Mental Health
(NOT-MH-23-105)National Institute of Mental Health
-
NOTICE OF NINR TECHNICAL ASSISTANCE WEBINAR FOR RFA-NR-23-001
(NOT-NR-23-001)National Institute of Nursing ResearchNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthOffice of Disease PreventionNational Institute on Minority Health and Health Disparities
-
Notice of Availability for Applicants to Verify Funding Tier Calculation for CTSA Program Funding Opportunities: PAR-21-293 (UM1), PAR-21-336 (K12), PAR-21-338 (T32), and PAR-21-337 (T32)
(NOT-TR-22-036)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notice of Changes to Funding Opportunities
-
Notice of Change to Eligible Organizations in PAR-22-250 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)"
(NOT-GM-23-002)National Institute of General Medical Sciences
-
Notice of Correction to Application and Submission Information for RFA-NS-22-029 "Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed)"
(NOT-NS-23-029)National Institute of Neurological Disorders and Stroke
-
Notice of Change to Funding Opportunity: Pilot Projects Increasing the Impact of the NIH Centers for Advancing Research on Botanicals and Other Natural Products (PI2 CARBON) (R03 Clinical Trials Not Allowed)
(NOT-OD-22-223)Office of Dietary SupplementsNational Center for Complementary and Integrative Health
-
Notice of Change in Eligibility for CTSA Program Funding Opportunities: PAR-21-336 (K12), PAR-21-339 (R25), PAR-21-338 (T32), and PAR-21-337 (T32)
(NOT-TR-22-035)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
(NOT-EB-22-009)National Institute of Biomedical Imaging and Bioengineering
-
Notice of Intent to Publish a Funding Opportunity Announcement for Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
(NOT-ES-22-014)National Institute of Environmental Health Sciences
-
Notice of Intent to Publish Funding Opportunity Announcements for Community Level Interventions to Prevent Firearm and Related Violence, Injury and Mortality
(NOT-OD-23-003)Office of Behavioral and Social Sciences Research
Notices of Special Interest
-
Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation
(NOT-AI-22-072)National Institute of Allergy and Infectious DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental Health
-
Notice of Special Interest (NOSI): Targeting the Pathogen within the Arthropod Vector
(NOT-AI-22-074)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Understanding Exposure and Health Effects of Micro and/or Nanoplastics
(NOT-ES-23-002)National Institute of Environmental Health Sciences
-
Notice of Special Interest: Impact of Childhood Sexual Abuse on Gynecologic Health and Disease
(NOT-HD-22-045)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program KL2/K12 Institutional Career Development Awards as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
(NOT-OD-22-192)Office of the Director, NIHNational Institute of Dental and Craniofacial ResearchNational Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Funding Opportunities
-
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Research Short Course (R25 Independent Clinical Trial Not Allowed)
(PAR-22-195)Office of the Director, NIHNational Institute on AgingNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Neurological Disorders and StrokeJohn E. Fogarty International CenterNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Multiple dates, see announcement.
-
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
(PAR-23-034)National Library of MedicineApplication Receipt Date(s): January 7, 2025
-
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Required)
(RFA-AG-23-034)National Institute on AgingApplication Receipt Date(s): January 20, 2023
-
Genetic Tools for Understanding Rickettsial and Related Infections (R61/R33 Clinical Trial Not Allowed)
(RFA-AI-22-047)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): February 14, 2023
-
Immunity in Older Adults (U01 Clinical Trial Not Allowed)
(RFA-AI-22-060)National Institute of Allergy and Infectious DiseasesNational Institute on AgingNational Institute of Dental and Craniofacial ResearchOffice of Research on Women's HealthApplication Receipt Date(s): February 14, 2023
-
Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33 Clinical Trial Not Allowed)
(RFA-AI-22-068)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): February 14, 2023
-
Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)
(RFA-CA-22-042)National Cancer InstituteNational Institute on Drug AbuseApplication Receipt Date(s): October 16, 2023
-
Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required)
(RFA-CA-22-043)National Cancer InstituteNational Institute on Drug AbuseApplication Receipt Date(s): October 16, 2023
-
Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)
(RFA-CA-22-051)National Cancer InstituteApplication Receipt Date(s): Not Applicable
-
Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed)
(RFA-CA-22-052)National Cancer InstituteNational Institute on Drug AbuseNational Center for Complementary and Integrative HealthApplication Receipt Date(s): February 17, 2023
-
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed)
(RFA-CA-22-056)National Cancer InstituteApplication Receipt Date(s): December 15, 2023
-
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)
(RFA-CA-22-057)National Cancer InstituteApplication Receipt Date(s): December 15, 2023
-
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional)
(RFA-DA-23-061)National Institute on Drug AbuseApplication Receipt Date(s): November 14, 2024
-
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)
(RFA-DA-23-062)National Institute on Drug AbuseApplication Receipt Date(s): November 14, 2024
-
Human Islet Research Network (HIRN) Pancreas Knowledgebase Program (PanKbase) (U24 - Clinical Trial Not Allowed)
(RFA-DK-22-018)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): March 31, 2023
-
Biological Basis for how Environmental Exposures Impact Risk for Psychiatric Disorders (R01 Clinical Trial Not Allowed)
(RFA-ES-22-008)National Institute of Environmental Health SciencesApplication Receipt Date(s): February 22, 2023
-
Biological Basis for how Environmental Exposures Impact Risk for Psychiatric Disorders (R21 Clinical Trial Not Allowed)
(RFA-ES-22-009)National Institute of Environmental Health SciencesApplication Receipt Date(s): February 22, 2023
-
Centers of Excellence in Regulatory Science and Innovation (CERSI) (U01) Clinical Trials Optional
(RFA-FD-23-004)Food and Drug AdministrationApplication Receipt Date(s): December 22, 2022
-
Learning Disabilities Research Centers (P50 Clinical Trial Optional)
(RFA-HD-23-022)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): December 29, 2022
-
BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed)
(RFA-MH-22-290)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): February 1, 2023
-
BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed)
(RFA-MH-22-291)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): February 1, 2023
-
BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (R01 Clinical Trial Not Allowed)
(RFA-MH-22-292)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): February 1, 2024
-
Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research Training Programs (T32)
(RFA-OD-22-027)Office of Nutrition ResearchNational Institute on AgingNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): December 08, 2022
-
Community Partnerships to Advance Science for Society (ComPASS): Coordination Center (U24 Clinical Trial Optional)
(RFA-RM-23-001)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): January 27, 2023
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: December 4, 2024
For technical issues E-mail OER Webmaster